Iovance Biotherapeutics, Inc. IOVA
Set alert
8.02 USD -0.46 -5.42%
At close
8.00 -0.02 -0.27%
Pre-market · Nov 3, 4:26 AM ET
7.66 Day range 8.56
1.76 52-week range 15.37
- YTD
- +193.77%
- 1 year
- +307.11%
- Open
- 8.53
- Prev close
- 8.48
- Mkt cap
- 3.63B
- Vol
- 21.05M
- Avg vol
- 17.24M
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.66
- High
- 8.56
- Forward P/E
- -40.97
- Beta
- 0.84
- Short ratio
- 3.26
- Inst. own
- 70.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 11.37
- 200-d avg
- 5.84
- 1y target
- 14.20
MAX chart
Events in this range
- Aug 7, 2025Earnings: -0.33; estimate -0.29; surprise -13.79%
- Nov 6, 2025Earnings: -0.25; estimate -0.29; surprise 13.79%
- May 7, 2026Earnings: -0.19; estimate -0.19; surprise 0%
- Aug 6, 2026Earnings: -0.11; estimate -0.13346; surprise 17.58%
- Nov 5, 2026Earnings: —; estimate -0.08459; surprise —%
Signals (56)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| MACD: Buy Signal | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| MACD: Sell Signal | Feb 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| SMA: Bearish | May 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| SMA: Bearish | Aug 1, 2023 | 3 years ago |
| SMA: Bullish | Jul 1, 2023 | 3 years ago |
| SMA: Bearish | Jun 1, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 1, 2023 | 3 years ago |
| SMA: Bullish | May 1, 2023 | 3 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| MACD: Sell Signal | Apr 1, 2021 | 5 years ago |
Newest 20 of 56.
Analyst view
Consensus: buy
Buy
Price target (mean) 14.20 +77.1% upside
Now 8.02
- Target (low)
- 7.00
- Target (mean)
- 14.20
- Target (high)
- 20.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 10
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.08525 | -0.10 – -0.072 | -0.25 | +65.9% | 114.98M | +70.5% | 8 |
| Next quarter | -0.08025 | -0.12 – -0.042 | -0.18 | +55.4% | 127.02M | +46.4% | 8 |
| Current year | -0.451 | -0.50 – -0.408 | -1.09 | +58.6% | 412.73M | +56.6% | 8 |
| Next year | -0.19575 | -0.42 – -0.10 | -0.451 | +56.6% | 593.63M | +43.8% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 8, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Sep 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 17, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 25, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 20, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 18, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| May 7, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Apr 10, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 3, 2026 | Citizens | Upgrade | Market Perform | Market Outperform |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Citizens | Upgrade | Market Perform | Market Outperform |
| Dec 17, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 24, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 6, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Oct 29, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 19, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 8, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jul 23, 2025 | Chardan Capital | Maintained | Buy | Buy |
| May 16, 2025 | UBS | Downgrade | Buy | Neutral |
| May 12, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| May 12, 2025 | Mizuho | Maintained | Outperform | Outperform |
| May 12, 2025 | Barclays | Maintained | Overweight | Overweight |
| May 9, 2025 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| May 9, 2025 | Chardan Capital | Maintained | Buy | Buy |